Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study.
Michael T MarroneAlison M MondulAnna E PrizmentDavid J CouperJohn R BarberMeera R ChappidiCorinne E JoshuElizabeth A PlatzPublished in: JNCI cancer spectrum (2021)
This study provides additional evidence for inverse associations between lipid-lowering drug use and cancer incidence and mortality but a positive association with bladder cancer incidence in men. Evaluation of the impact of chemoprevention strategies that include lipid-lowering drugs on population-level cancer burden is needed.